Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2014 2
2015 1
2016 2
2017 2
2018 2
2019 5
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective.
van Leeuwen RW, van Gelder T, Mathijssen RH, Jansman FG. van Leeuwen RW, et al. Lancet Oncol. 2014 Jul;15(8):e315-26. doi: 10.1016/S1470-2045(13)70579-5. Lancet Oncol. 2014. PMID: 24988935 Review.
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen.
Hussaarts KGAM, Hurkmans DP, Oomen-de Hoop E, van Harten LJ, Berghuis S, van Alphen RJ, Spierings LEA, van Rossum-Schornagel QC, Vastbinder MB, van Schaik RHN, van Gelder T, Jager A, van Leeuwen RWF, Mathijssen RHJ. Hussaarts KGAM, et al. Among authors: van leeuwen rwf. Cancers (Basel). 2019 Mar 22;11(3):403. doi: 10.3390/cancers11030403. Cancers (Basel). 2019. PMID: 30909366 Free PMC article.
Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules.
Zhou G, Sprengers D, Mancham S, Erkens R, Boor PPC, van Beek AA, Doukas M, Noordam L, Campos Carrascosa L, de Ruiter V, van Leeuwen RWF, Polak WG, de Jonge J, Groot Koerkamp B, van Rosmalen B, van Gulik TM, Verheij J, IJzermans JNM, Bruno MJ, Kwekkeboom J. Zhou G, et al. Among authors: van leeuwen rwf. J Hepatol. 2019 Oct;71(4):753-762. doi: 10.1016/j.jhep.2019.05.026. Epub 2019 Jun 11. J Hepatol. 2019. PMID: 31195061
Clinically relevant drug interactions with multikinase inhibitors: a review.
Hussaarts KGAM, Veerman GDM, Jansman FGA, van Gelder T, Mathijssen RHJ, van Leeuwen RWF. Hussaarts KGAM, et al. Among authors: van leeuwen rwf. Ther Adv Med Oncol. 2019 Jan 4;11:1758835918818347. doi: 10.1177/1758835918818347. eCollection 2019. Ther Adv Med Oncol. 2019. PMID: 30643582 Free PMC article. Review.
The Risk of QTc-Interval Prolongation in Breast Cancer Patients Treated with Tamoxifen in Combination with Serotonin Reuptake Inhibitors.
Hussaarts KGAM, Berger FA, Binkhorst L, Oomen-de Hoop E, van Leeuwen RWF, van Alphen RJ, Mathijssen-van Stein D, de Groot NMS, Mathijssen RHJ, van Gelder T. Hussaarts KGAM, et al. Among authors: van leeuwen rwf. Pharm Res. 2019 Dec 16;37(1):7. doi: 10.1007/s11095-019-2746-9. Pharm Res. 2019. PMID: 31845095 Free PMC article.
Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.
van Leeuwen RW, Peric R, Hussaarts KG, Kienhuis E, IJzerman NS, de Bruijn P, van der Leest C, Codrington H, Kloover JS, van der Holt B, Aerts JG, van Gelder T, Mathijssen RH. van Leeuwen RW, et al. J Clin Oncol. 2016 Apr 20;34(12):1309-14. doi: 10.1200/JCO.2015.65.2560. Epub 2016 Feb 8. J Clin Oncol. 2016. PMID: 26858332 Clinical Trial.
Reply to N. Singh et al.
van Leeuwen RWF, van Gelder T, Aerts JG, Mathijssen RHJ. van Leeuwen RWF, et al. J Clin Oncol. 2016 Nov 20;34(33):4054. doi: 10.1200/JCO.2016.68.9356. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27551130 No abstract available.
Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.
Hussaarts KGAM, van Leeuwen RWF, Mathijssen RHJ. Hussaarts KGAM, et al. Among authors: van leeuwen rwf. JAMA Oncol. 2018 Feb 1;4(2):263-264. doi: 10.1001/jamaoncol.2016.7019. JAMA Oncol. 2018. PMID: 29098281 No abstract available.
Clinical implications of food-drug interactions with small-molecule kinase inhibitors.
Veerman GDM, Hussaarts KGAM, Jansman FGA, Koolen SWL, van Leeuwen RWF, Mathijssen RHJ. Veerman GDM, et al. Among authors: van leeuwen rwf. Lancet Oncol. 2020 May;21(5):e265-e279. doi: 10.1016/S1470-2045(20)30069-3. Lancet Oncol. 2020. PMID: 32359502 Review.
Influence of Enzalutamide on Cabazitaxel Pharmacokinetics: a Drug-Drug Interaction Study in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients.
Belderbos BPS, Bins S, van Leeuwen RWF, Oomen-de Hoop E, van der Meer N, de Bruijn P, Hamberg P, Overkleeft ENM, van der Deure WM, Lolkema MP, de Wit R, Mathijssen RHJ. Belderbos BPS, et al. Among authors: van leeuwen rwf. Clin Cancer Res. 2018 Feb 1;24(3):541-546. doi: 10.1158/1078-0432.CCR-17-2336. Epub 2017 Nov 17. Clin Cancer Res. 2018. PMID: 29150561 Free article.
18 results
Jump to page
Feedback